Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells

Abstract

The level of vascular endothelial growth inhibitor (VEGI) has been reported to be negatively associated with neovascularization in malignant tumors. The soluble form of VEGI is a potent anti-angiogenic factor due to its effects in inhibiting endothelial cell proliferation. This inhibition is mediated by death receptor 3 (DR3), which contains a death domain in its cytoplasmic tail capable of inducing apoptosis that can be subsequently blocked by decoy receptor 3 (DcR3). We investigated the effects of sodium valproate (VPA) and trichostatin A (TSA), histone deacetylase inhibitors, on the expression of VEGI and its related receptors in human osteosarcoma (OS) cell lines and human microvascular endothelial (HMVE) cells. Consequently, treatment with VPA and TSA increased the VEGI and DR3 expression levels without inducing DcR3 production in the OS cell lines. In contrast, the effect on the HMVE cells was limited, with no evidence of growth inhibition or an increase in the DR3 and DcR3 expression. However, VPA-induced soluble VEGI in the OS cell culture medium markedly inhibited the vascular tube formation of HMVE cells, while VEGI overexpression resulted in enhanced OS cell death. Taken together, the HDAC inhibitor has anti-angiogenesis and antitumor activities that mediate soluble VEGI/DR3-induced apoptosis via both autocrine and paracrine pathways. This study indicates that the HDAC inhibitor may be exploited as a therapeutic strategy modulating the soluble VEGI/DR3 pathway in osteosarcoma patients.

The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism

“…Previous studies have identified multiple genetic targets affected by HDAC inhibition in various mammalian cell types, including those associated with pluripotency , lineage‐specific differentiation , and cytokine production . In Figure A, quantitative PCR (qPCR)‐based gene expression assays were used to assess the concentration‐dependent effects of NaBu on CMC gene transcription.…”

Valproic acid enhances the viability of random pattern skin flaps: involvement of enhancing angiogenesis and inhibiting oxidative stress and apoptosis

“… 10 However, in other studies, VPA was antiangiogenic in models of several cancers. 19 , 20 Thus, the effect of VPA on angiogenesis remains controversial, perhaps attributable to differential regulation of key genes and proteins in various disease microenvironments. The effect of VPA on random skin flap angiogenesis remains poorly understood.…”

Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review

“…VPA induced the Bcl-2 phosphorylation and release of the cytochrome c via activating ERK1/2 and consequently inhibited the serum starvation-induced HUVECs apoptosis (Michaelis et al, 2006). Comparatively, VPA was found to induce apoptosis of tumor cells (Yamanegi et al, 2015).…”